CapitalBull
Empowered Funds Boosts XRAY Stake by 515%
Empowered Funds increased XRAY holdings by 515.3% in Q1, indicating rising institutional interest.
D1 -3.8% · +5d -4.0%
Earnings
XRAY Q2 Beat but Revenue Down 4.1%, Stock Falls, Guidance Maintained
Q2 revenue decline, Wellspect growth, margin improvement, guidance maintained, stock falls
D1 -8.0% · +5d -4.4%
›2 waves of this story
- 2026-08-07 Q2 revenue declined but beat estimates; Wellspect growth offset dental weakness, margins improved, 2026 guidance maintained.
- 2026-08-07 Q2 revenue decline, Wellspect growth, margin improvement, guidance maintained, stock falls
6 earlier events›
EarningsBull
DENTSPLY SIRONA Q2 Earnings Beat Estimates at $0.52/share
Q2 EPS of $0.52 beat Zacks estimate of $0.36; earnings call transcript available
D1 +1.0% · +5d -18.6%
›2 waves of this story
- 2026-08-04 Q2 results likely reflect transformation investments, dealer inventory cuts, and weak implants, with Wellspect growth as support.
- 2026-08-06 Q2 EPS of $0.52 beat Zacks estimate of $0.36; earnings call transcript available
Earnings
Earnings report
D1 -4.4% · +5d -12.1%
CapitalBull
Dimensional Fund Advisors Raises Stake in DENTSPLY SIRONA by 31.4%
Per 13F filing, Dimensional Fund Advisors increased its XRAY position by 31.4% in the latest quarter.
D1 +1.0% · +5d -18.6%
8-K filing
8-K: Item 5.02, Item 7.01, Item 9.01
D1 +1.0% · +5d +1.9%
8-K filing
8-K: Item 2.02, Item 9.01
D1 +1.5% · +5d -3.3%
Earnings
Earnings report
D1 +1.5% · +5d -3.3%
be the first
Be civil · your views are your own
Facts and opinions separated · All items sourced · Not investment advice
